skip to main content

Chemistry, part 1

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > ganglioside > sialotriaosylceramide > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > ganglioside > sialotriaosylceramide > ganglioside gm2 (18:0)
... > organooxygen compound > sphingolipid > ceramide > ganglioside > sialotriaosylceramide > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > ganglioside > sialotriaosylceramide > ganglioside gm2 (18:0)
... > organooxygen compound > carboxamide > ceramide > ganglioside > sialotriaosylceramide > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > ganglioside > sialotriaosylceramide > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > ganglioside gm2 (18:0)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > ganglioside gm2 (18:0)
... > organooxygen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > organooxygen compound > sphingolipid > ceramide > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > organooxygen compound > carboxamide > ceramide > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > organooxygen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > organooxygen compound > sphingolipid > ceramide > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > organooxygen compound > carboxamide > ceramide > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)
... > organooxygen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > n-acetyl-beta-d-galactosaminyl-(1->4)-alpha-n-acetylneuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-n-acylsphingosine > ganglioside gm2 (18:0)

Preferred term

ganglioside gm2 (18:0)  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C67H121N3O26

has_role

inchi

  • InChI=1S/C67H121N3O26/c1-5-7-9-11-13-15-17-19-20-22-24-26-28-30-32-34-50(80)70-43(44(77)33-31-29-27-25-23-21-18-16-14-12-10-8-6-2)40-89-64-57(85)56(84)59(48(38-73)91-64)93-65-58(86)62(60(49(39-74)92-65)94-63-52(69-42(4)76)55(83)54(82)47(37-72)90-63)96-67(66(87)88)35-45(78)51(68-41(3)75)61(95-67)53(81)46(79)36-71/h31,33,43-49,51-65,71-74,77-79,81-86H,5-30,32,34-40H2,1-4H3,(H,68,75)(H,69,76)(H,70,80)(H,87,88)/b33-31+/t43-,44+,45-,46+,47+,48+,49+,51+,52+,53+,54-,55+,56+,57+,58+,59+,60-,61+,62+,63-,64+,65-,67-/m0/s1

inchikey

  • GIVLTTJNORAZON-HDBOBKCLSA-N

is_conjugate_acid_of

mass

  • 1384.68210

monoisotopicmass

  • 1383.82383

smiles

  • [H][C@]1(O[C@@](C[C@H](O)[C@H]1NC(C)=O)(O[C@@H]1[C@@H](O)[C@@H](O[C@H](CO)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1NC(C)=O)O[C@@H]1[C@@H](CO)O[C@@H](OC[C@H](NC(=O)CCCCCCCCCCCCCCCCC)[C@H](O)/C=C/CCCCCCCCCCCCC)[C@H](O)[C@H]1O)C(O)=O)[C@H](O)[C@H](O)CO

subset

  • 3_STAR

synonym EXACT

  • (2S,3R,4E)-3-hydroxy-2-(octadecanoylamino)octadec-4-en-1-yl 2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)]-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside

synonym RELATED

  • beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-N-octadecanoylsphingosine
  • beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-N-stearoylsphingosine
  • ganglioside GM2 (18:1/18:0)
  • GM2
  • GM2 ganglioside
  • G(M2) ganglioside
  • GM2 lipid
  • monosialoganglioside GM2
  • Tay-Sachs ganglioside

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:60327

Download this concept:

RDF/XML TURTLE JSON-LD